UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000040820
Receipt No. R000044961
Scientific Title Research on the Association Between Fostering Self-Management and Neuromodulators Among Community-Dwelling People with Chronic Musculoskeletal Pain
Date of disclosure of the study information 2020/06/27
Last modified on 2021/06/21 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Community-Based Epidemiological Study on the Effect of Individualized Self-Management Support of Low Back Pain After Health Check
Acronym Community-Based Epidemiological Study on the Effect of Individualized Self-Management Support of Low Back Pain After Health Check
Scientific Title Research on the Association Between Fostering Self-Management and Neuromodulators Among Community-Dwelling People with Chronic Musculoskeletal Pain
Scientific Title:Acronym Research on the Association Between Fostering Self-Management and Neuromodulators Among Community-Dwelling People with Chronic Musculoskeletal Pain
Region
Japan

Condition
Condition Chronic low back pain
Classification by specialty
Orthopedics Rehabilitation medicine Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study is a randomized controlled trial of middle-aged and older community people with chronic low back pain to assess that pain self-management education improves pain symptoms and change levels of neuromodulator such as serum beta-endorphin and serotonin.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Severity of low back pain (RDQ)
Key secondary outcomes Pain intensity (NRS)
Pain self-efficacy (PSEQ)
Serum neuromodulators

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -but assessor(s) are blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Educational,Counseling,Training
Type of intervention
Behavior,custom
Interventions/Control_1 Self-exercise and pain education
Interventions/Control_2 Control (waiting-list control)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit
79 years-old >=
Gender Male and Female
Key inclusion criteria People i) with low back pain persisting for at least 3 months at the time of the survey, ii) aged 40-79 years, and iii) with provision of informed consent to participate in the study.
Key exclusion criteria People i) with suspected specific low back pain (e.g. intervertebral disc herniation, and spinal compression fracture), ii) with severe neurologic deficits, iii) who use of selective serotonin reuptake inhibitors or antidepressants, iv) who could not accommodate the study schedule, v) with a scheduled move or long-term trip within a year, vi) with difficulty comprehending the Japanese language, vii) with obvious cognitive impairment which would make difficult to answer the questionnaires and/or to provide consent, or viii) who were deemed ineligible by a public health or orthopedic doctor.
Target sample size 68

Research contact person
Name of lead principal investigator
1st name Hiroshige
Middle name
Last name Jinnnouchi
Organization Nippon Medical School
Division name Department of Hygiene and Public Health
Zip code 113-0031
Address 1-25-16 Nezu, Bunkyo-Ku, Tokyo
TEL 03-3822-2131
Email h-jinnouchi@nms.ac.jp

Public contact
Name of contact person
1st name Hiroshige
Middle name
Last name Jinnouchi
Organization Nippon Medical School
Division name Department of Hygiene and Public Health
Zip code 113-0031
Address 1-25-16 Nezu, Bunkyo-Ku, Tokyo
TEL 03-3822-2131
Homepage URL
Email h-jinnouchi@nms.ac.jp

Sponsor
Institute Nippon Medical School
Institute
Department

Funding Source
Organization Nippon Medical School
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor Osaka Center for Cancer and Cardiovascular Disease Prevention
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board of Nippon Medical School
Address 1-1-5 Sendagi, Bunkyo-Ku, Tokyo
Tel 03-3822-2131
Email nms_rinri@nms.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 06 Month 27 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2020 Year 01 Month 31 Day
Date of IRB
2020 Year 01 Month 31 Day
Anticipated trial start date
2022 Year 02 Month 28 Day
Last follow-up date
2024 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 06 Month 18 Day
Last modified on
2021 Year 06 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000044961